[1] Liu Z M, Fan H M, Jiang S P,et al. CD4(+) T-cell subsets in transplantation[J]. Immunol Rev, 2013,252(1):183-191.
[2] Heon P, Li Z X,O Yang X X,et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17[J]. Nat Immunol, 2005,6(11): 1133-1141.
[3] Thomas K, Estelle B, Mohamed O, et al. IL-17 and Th17 Cells[J]. Annu Rev Immunol, 2009, 27: 485-517.
[4] Elisabetta V, Nicolas S, Raphae¨ Z,et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses[J]. Nat Immunol, 2008,9(6): 650-657.
[5] Zhu J F, Hidehiro Y, William E P, Differentiation of effector CD4 T cell populations [J]. Annu Rev Immunol, 2010,28: 445-489.
[6] Galle B, Elizabeth M. B, Ester L, et al. TGF-beta induces IL-9 production from human Th17 cells[J] .J Immunol, 2010,185(1): 46-54.
[7] Maria C,Aviv M, Carolina G, et al. A validated regulatory network for Th17 cell specification[J]. Cell, 2012, 151(2): 289-303.
[8] Shigeru T,Akira S,Taro I, et al. Sox5 and c-Maf cooperatively induce Th17 cell differentiation via RORgammat induction as downstream targets of Stat3[J]. J Exp Med, 2014,211(9): 1857-1874.
[9] Aki U, Zhou L, Paul L S.et al.Fyn promotes Th17 differentiation by regulating the kinetics of RORgammat and Foxp3 expression[J]. J Immunol, 2012,188(11): 5247-5256.
[10] Afzali B, Mitchell P, Lechler R I, et al. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells[J]. Clin Exp Immunol, 2010,159(2): 120-130.
[11] Lewis Z. S, Wang R N, Huang G H, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells[J]. J Exp Med, 2011,208(7): 1367-1376.
[12] Julio G R, Elizabeth A W, Robin H, et al.Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells[J]. J Exp Med, 2014,211(3): 529-543.
[13] Madhumita J B, Marie E M, Hyunjin S, et al. Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes[J]. J Immunol, 2011,186(2): 1162-1172.
[14] Jarno H, Janne K N, Gao H, et al. IL-17 immunity in human type 1 diabetes[J]. J Immunol, 2010,185(3): 1959-1967.
[15] Clémence D, Valérie A A, Aurélie D, et al. Intragraft Th17 infiltrate promotes lymphoid neogenesis and hastens clinical chronic rejection[J]. J Immunol, 2010,184(9): 5344-5351.
[16] Shuhei N, Hitoshi K, Sanae T, et al. Th17 cells carrying TCR recognizing epidermal autoantigen induce psoriasis-like skin inflammation[J]. J Immunol, 2013,191(6): 3065-3072.
[17] Jeppe R C, Lars B, Rikke R, et al. Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression[J]. PLos One, 2013,8(3): e57820.
[18] Hu F L, Li Y G, Zheng ,et al. Toll-like receptors expressed by synovial fibroblasts perpetuate Th1 and th17 cell responses in rheumatoid arthritis[J]. PLos One, 2014,9(6): e100266.
[19] Maria S L, Alan M, Aiping B, et al. Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease[J]. PLos One, 2014,9(2): e87956.
[20] Zhao Y , Yang J , Gao Y D , et al. Th17 immunity in patients with allergic asthma[J]. Int Arch Allergy Immunol, 2010,151(4): 297-307.